ADHD PHARMA LTD
Opportunity 71/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (55/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
- • 1 address
Corporate timeline (5 events)Click to expand
- 2026-01-07📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-11-14🏢Company incorporatedAs ADHD PHARMA LTD
- 2025-11-14➕FAZAL, Mohammed Kamran appointeddirector
- 2025-11-14➕FAZAL, Zaakir Hussain appointeddirector
- 2025-11-14📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
- +Young company: Only 0.6 years old — management layer unlikely to be developed.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Zaakir Hussain Fazal Individual · British · DOB 10/2000 · age 26 | 25–50% | — | 25-50% shares | 14/11/2025 |
Mr Mohammed Kamran Fazal Individual · British · DOB 05/1998 · age 28 | 25–50% | — | 25-50% shares | 14/11/2025 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · BL postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A. FLETCHER LIMITED→ 04459941 · est 2002 · no financials extracted | — | — | — | — | 23y | — | — |
| ABL HEALTH LIMITED→ 07074944 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| ABUKA'S DEN LTD→ 13182189 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ABZ EL TOURKY LIMITED→ 15820119 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AC (ENGLAND) LIMITED→ 12216515 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ACESO MEDICAL LIMITED→ 08344864 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
| ADEBAYOR UK LIMITED→ 12011477 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ADHAN ENTERPRISES LTD→ 13634065 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ADONAI'S HAVEN LIMITED→ 16198780 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ADVENTURE GARDEN LIMITED→ 16721443 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ADVOCARE LIMITED→ 09995736 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| AESTHETIC ATHLETES LTD→ 12748245 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.